Literature DB >> 3149700

Pattern reversal visual evoked potentials in phenylketonuria.

M Giovannini1, R Valsasina, R Villani, A Ducati, E Riva, A Landi, R Longhi.   

Abstract

The pathogenesis of brain dysfunction in phenylketonuria (PKU) is still under investigation. Hyperphenylalaninaemia results in increased turnover of myelin. In order to demonstrate the derangement of myelinization in PKU we studied the visual evoked potentials (VEP) in 14 PKU patients and in 20 normal subjects. VEP findings were correlated with the metabolic control of the disease and with the electroencephalographic findings. VEP were more sensitive than the EEG in detecting a neurological dysfunction. VEP are influenced by dietary control and are normal only in children with good metabolic control.

Entities:  

Mesh:

Year:  1988        PMID: 3149700     DOI: 10.1007/bf01800430

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  14 in total

1.  Neuropathological findings in phenyl-pyruvic oligophrenia (phenyl-ketonuria).

Authors:  E C ALVORD; L D STEVENSON; F S VOGEL; R L ENGLE
Journal:  J Neuropathol Exp Neurol       Date:  1950-07       Impact factor: 3.685

2.  Lipid composition of human cerebral white matter and myelin in phenylketonuria.

Authors:  S N Shah; N A Peterson; C M McKean
Journal:  J Neurochem       Date:  1972-10       Impact factor: 5.372

3.  The influence of high phenylalanine and tyrosine on the concentrations of essential amino acids in brain.

Authors:  C M McKean; D E Boggs; N A Peterson
Journal:  J Neurochem       Date:  1968-03       Impact factor: 5.372

4.  Cranial computerized tomography in phenylketonuria.

Authors:  A W Behbehani; H Krtsch; F J Schulte
Journal:  Neuropediatrics       Date:  1981-11       Impact factor: 1.947

5.  Cerebral lipids in phenylketonuria.

Authors:  J H Menkes
Journal:  Pediatrics       Date:  1966-06       Impact factor: 7.124

6.  Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia.

Authors:  I J Butler; M E O'Flynn; W E Seifert; R R Howell
Journal:  J Pediatr       Date:  1981-05       Impact factor: 4.406

7.  Role of the liver in the pathogenesis of cerebral disorders in phenylketonuria.

Authors:  Y I Barashnev; V V Korneichuk; A I Klembovsky; L A Klyushina
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

8.  Pattern evoked potentials in phenylketonuria.

Authors:  D Creel; B A Buehler
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1982-02

9.  Computer analysis of the EEG as an aid in the evaluation of dietetic treatment in phenylketonuria.

Authors:  D N Donker; D Reits; F J Van Sprang; W S van Leeuwen; S K Wadman
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1979-02

10.  Inhibition by L-phenylalanine of tryptophan transport by synaptosomal plasma membrane vesicles: implications in the pathogenesis of phenylketonuria.

Authors:  E Herrero; M C Aragon; C Gimenez; F Valdivieso
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

View more
  6 in total

1.  Studies of multimodal evoked potentials in treated phenylketonuria: the pattern of vulnerability.

Authors:  A C Ludolph; U Vetter; K Ullrich
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

2.  Spasticity and white matter abnormalities in adult phenylketonuria.

Authors:  P A McCombe; D B McLaughlin; J B Chalk; N N Brown; J J McGill; M P Pender
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

3.  Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations.

Authors:  V Leuzzi; S Rinalduzzi; F Chiarotti; P Garzia; G Trasimeni; N Accornero
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

4.  Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and IQ.

Authors:  S J Jones; G Turano; A Kriss; F Shawkat; B Kendall; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

Review 5.  White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings.

Authors:  U Bick; K Ullrich; U Stöber; H Möller; G Schuierer; A C Ludolph; C Oberwittler; J Weglage; U Wendel
Journal:  Eur J Pediatr       Date:  1993-12       Impact factor: 3.183

6.  Pre-attentive processing in children with early and continuously-treated PKU. Effects of concurrent Phe level and lifetime dietary control.

Authors:  Leo M J de Sonneville; Stephan C J Huijbregts; Robert Licht; Joseph A Sergeant; Francjan J van Spronsen
Journal:  J Inherit Metab Dis       Date:  2011-05-04       Impact factor: 4.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.